Fig. 1From: Pharmacodynamic and pharmacokinetic behavior of landiolol during dobutamine challenge in healthy adultsTime courses of the concentrations of landiolol and its metabolites LM1 and LM2 in whole blood when administered for 60 min on top of continuous dobutamine infusion in healthy volunteers (n = 16). Median values are shown. Solid line and diamonds: landiolol; broken line and squares: LM1; dotted line and triangles: LM2Back to article page